Personalized Treatment Plans
482 articles
Highlights from the 2025 AACR Annual Meeting
Drugs to target KRAS, better imaging for earlier detection, and cachexia prediction are among the research highlights from AACR 2025.
Pancreatic Cancer Research Highlights from ASCO Annual Meeting
The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.
PARP Inhibitors for Pancreatic Cancer Maintenance Treatment
Dr. Kim Reiss Binder is leading a clinical trial of maintenance treatment with the PARP inhibitor rucaparib, for patients who carry the BRCA mutation.
Testing Standard Treatment Plus an Antibody to Shrink Pancreatic Tumors
Researchers are testing whether adding a monoclonal antibody to standard chemotherapy will make locally advanced pancreatic cancer qualify for surgery.
Using Molecular Tumor Profiling to Determine the Best Pancreatic Cancer Treatment
A clinical trial looks at whether molecular subtyping of tumors is effective in determining the best pancreatic cancer treatment.
Genetic Testing and Molecular Profiling Can Guide Treatment
Watch our webinar on Genetic Testing and Molecular Profiling to learn from experts and patients why this is so important.
Pancreatic Cancer and Drug Interactions: What You Need to Know
Pharmacist Trevor Christ emphasizes the importance of sharing your medication list with your medical team and pharmacist.
Support Groups Provide an Emotional Lift
Social worker Angie Heller knows the value of pancreatic cancer support groups. She leads a group at Columbia University Medical Center’s Pancreas Center.